Key facts
- This page summarizes Scot Michael Elder's Form 4 filing for TREACE MEDICAL CONCEPTS, INC. (TMCI).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 11 Mar 2026, 21:00.
Scot Michael Elder - 08 Mar 2026 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)
- Reporting relationship
- Chief Legl & Comp Off, CorpSec
- Issuer ticker
- TMCI
- Reported as of
- 08 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 11 Mar 2026, 21:00:07 UTC
- Prior SEC filing
- 23 Jan 2026
- Next SEC filing
- 12 Aug 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lisa Taylor as Attorney-in-fact for Scot Elder
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Scot Michael Elder filed Form 4 for TREACE MEDICAL CONCEPTS, INC. (TMCI) on 11 Mar 2026.
Change
- Previous filing in this sequence was filed on 23 Jan 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001916619
Primary reporting owner
Elder Scot Michael
- Relationship
- Chief Legl & Comp Off, CorpSec
- Address
- C/O TREACE MEDICAL CONCEPTS, INC., 100 PALMETTO PARK PLACE, PONTE VEDRA
- Signature
- /s/ Lisa Taylor as Attorney-in-fact for Scot Elder
- Signature date
- 11 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TMCI
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -175
- Change %
- -0.02%
- Price
- $0.000000*
- Shares after
- 796,611
- Date
- 08 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
TMCI
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -1,675
- Change %
- -0.21%
- Price
- $0.000000*
- Shares after
- 794,936
- Date
- 10 Mar 2026
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Includes 640,752 restricted stock units.
Footnote F2
Includes 633,877 restricted stock units.